BAX Baxter International Inc

  1. Stocks
  2. Healthcare
  3. NYSE: BAX

Price (delayed)

$25.815

Market cap

$13.36B

P/E Ratio

N/A

Dividend/share

$0.04

EPS

-$1.42

Enterprise value

$20.19B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 20

Every day, Baxter and the Baxter Foundation strive to make a meaningful difference in the lives of people who depend on our products, and in the communities where our employees ...

Highlights
Baxter International's debt has decreased by 9% YoY and by 9% from the previous quarter
The revenue is up by 5% year-on-year
The EPS has plunged by 115% YoY but it has grown by 32% from the previous quarter
BAX's net income has dropped by 112% year-on-year but it is up by 32% since the previous quarter
The gross margin is down by 12% year-on-year
The gross profit has declined by 7% year-on-year
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.baxter.com
Peers: CAH BSX SYK BDX

Key stats

What are the main financial stats of BAX

BAX stock price

How has the Baxter International stock price performed over time
Intraday
-1.99%
1 week
0.64%
1 month
4.18%
1 year
38.05%
YTD
35.09%
QTD
7.56%

Financial performance

How have Baxter International's revenue and profit performed over time
Revenue
$11.61B
Gross profit
$3.49B
Operating income
-$221M
Net income
-$723M
Gross margin
30.1%
Net margin
-6.2%
BAX's net income has dropped by 112% year-on-year but it is up by 32% since the previous quarter
Baxter International's net margin has plunged by 100% YoY but it has increased by 33% from the previous quarter
The operating margin has increased by 21% from the previous quarter
Baxter International's operating income has increased by 19% from the previous quarter

Price vs fundamentals

How does BAX's price correlate with its fundamentals

Growth

What is Baxter International's growth rate over time

Valuation

What is Baxter International stock price valuation
BAX P/E details
P/E
N/A
P/B
2.05
P/S
1.15
EV/EBIT
N/A
EV/EBITDA
22.11
EV/Sales
1.74
The EPS has plunged by 115% YoY but it has grown by 32% from the previous quarter
BAX's P/B is 25% below its 5-year quarterly average of 2.8 but 23% above its last 4 quarters average of 1.7
The company's equity fell by 10% YoY but it rose by 4.8% QoQ
BAX's P/S is 35% below its 5-year quarterly average of 1.8 but 30% above its last 4 quarters average of 0.9
The revenue is up by 5% year-on-year

Efficiency

How efficient is Baxter International business performance
The ROA has plunged by 147% YoY but it has grown by 30% from the previous quarter
The company's return on equity has shrunk by 142% YoY but it rose by 30% QoQ
The ROS has soared by 86% from the previous quarter
The ROIC has soared by 86% from the previous quarter

Dividends

What is BAX's dividend history
Dividend details
DPS
$0.04
Dividend yield
0.15%
Payout ratio
N/A
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Baxter International financials performed over time
The total assets is 50% more than the total liabilities
The quick ratio is down by 12% since the previous quarter but it is up by 6% year-on-year
The current ratio fell by 8% QoQ and by 2.7% YoY
Baxter International's debt is 35% more than its equity
The debt to equity has declined by 13% since the previous quarter
The company's equity fell by 10% YoY but it rose by 4.8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.